We are live on
!
Find out more
GHAM
Gilman Hill Asset Management Portfolio holdings
AUM
$731M
1-Year Est. Return
19.41%
This Fund
S&P 500
This Quarter
Est. Return
+2.17%
1 Year Est. Return
+19.41%
3 Year Est. Return
+50.69%
5 Year Est. Return
+55.12%
10 Year Est. Return
+172.02%
AUM
$137M
AUM Growth
–
Cap. Flow
+$138M
Cap. Flow
% of AUM
100.47%
Top 10 Holdings %
Top 10 Hldgs %
27.69%
Holding
121
New
121
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
McCormick & Company Non-Voting
MKC
|
+$7.53M |
| 2 |
Johnson & Johnson
JNJ
|
+$4.43M |
| 3 |
Pfizer
PFE
|
+$3.83M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$3.74M |
| 5 |
Verizon
VZ
|
+$3.21M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Energy | 15.71% |
| 2 | Consumer Staples | 12.3% |
| 3 | Healthcare | 11.43% |
| 4 | Industrials | 10.93% |
| 5 | Real Estate | 10.92% |
Similar funds
GIC
TVPW
IA
RP
GFI
AFAS
HGWM
ACM
Gilman Hill Asset Management's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for Gilman Hill Asset Management, which disclosed 121 positions worth $137M. Its ten largest holdings account for 28% of the portfolio.
Its largest position is McCormick & Company Non-Voting: 209,104 shares worth $7.37M.
By sector, the portfolio is most concentrated in Energy at 16% of assets, followed by Consumer Staples and Healthcare.
- Gilman Hill Asset Management's largest Q2 2013 buy was McCormick & Company Non-Voting: 209,104 shares worth $7.37M.
- Gilman Hill Asset Management's ten largest holdings make up 28% of its $137M portfolio in Q2 2013.
- Gilman Hill Asset Management disclosed 121 positions in Q2 2013, its first 13F filing on record.
Based on Gilman Hill Asset Management's 13F filing for Q2 2013, filed 19 Jul 2013.